Erin Humiston

A new report from the Centers for Medicare and Medicaid Services (CMS) paints a bleak picture of Obamacare’s 2018 health insurance exchange enrollment.

As China increases tariffs on 128 U.S. products and the first sparks of a trade war begin to fly, President Trump demonstrates a failure to learn lessons from history in his pursuit to make tariffs great again.

 For its next Hatton W. Sumners Distinguished Lecture Series event, IPI will host acclaimed civil liberties attorney Alan M. Dershowitz in Irving on Wednesday, March 28, 2018. The world-renowned litigator will share his concerns on the current state of political discourse.

President Trump has made a wise selection by appointing CNBC contributor, TV and radio host Larry Kudlow, whose creed is “free market capitalism is the best path to prosperity,” to be his chief economic advisor as head of the National Economic Council.

The Institute for Policy Innovation (IPI) is honored to host acclaimed civil liberties attorney Alan M. Dershowitz in Irving on Wednesday, March 28, 2018, as the next of its Hatton W. Sumners Distinguished Lecture Series.

"Twenty states have sued the Trump administration asserting that the tax reform law, which eliminates the Affordable Care Act's mandate to have health insurance, makes Obamacare unconstitutional," said Merrill Matthews. "It's a brilliant argument. 

Millennials are being fleeced as Washington continues to confiscate their wages to prop up the collapsing Social Security program. The Great Social Security Reckoning is on the horizon, and for several key reasons.

The Department of Labor’s proposed rulemaking released today would help clear the way for employers to band together in associations and self-insure, and is a good first step in the ongoing but challenging effort to provide employers and employees more flexibility under Obamacare.

In a new publication, “Budgets First, Patients Last: MedPAC's Plan to Undermine Medicare Part B's Drug Benefit,” Matthews says MedPAC’s proposed changes to Medicare Part B’s prescription drug reimbursement plan would put patients' lives at risk by reducing access to care, especially for the sickest and most vulnerable patients — a substantial segment of Medicare’s Part B drug program.

"We’re thankful that this mistake is soon to be overturned," said Tom Giovanetti.